Join
Live feed
·
PRReleasevia Quantisnow
Biogen Inc. logo
Denali Therapeutics Inc. logo

Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson's Disease

ByQuantisnow·Wall Street's wire, on your screen.
BIIB· Biogen Inc.DNLI· Denali Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIIB (Biogen Inc.), DNLI (Denali Therapeutics Inc.) and more on Quantisnow.